- JP-listed companies
- FRONTEO,Inc.
- Financials
- Net income margin (%)
FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 9.1 | -123.61% |
| Mar 31, 2024 | -38.5 | +63.49% |
| Mar 31, 2023 | -23.6 | -296.97% |
| Mar 31, 2022 | 12 | +238.90% |
| Mar 31, 2021 | 3.5 | -140.49% |
| Mar 31, 2020 | -8.7 | -1674.87% |
| Mar 31, 2019 | 0.6 | -108.28% |
| Mar 31, 2018 | -6.7 | -20.38% |
| Mar 31, 2017 | -8.4 | +364.32% |
| Mar 31, 2016 | -1.8 | -143.33% |
| Mar 31, 2015 | 4.2 | -128.88% |
| Mar 31, 2014 | -14.5 | -239.84% |
| Mar 31, 2013 | 10.3 | -58.27% |
| Mar 31, 2012 | 24.8 |